Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer's disease

Oncotarget. 2016 Nov 8;7(45):72469-72474. doi: 10.18632/oncotarget.12505.

Abstract

In recent years, several pathway analyses of genome-wide association studies reported the involvement of metabolic and immune pathways in Alzheimer's disease (AD). Until now, the exact mechanisms of these pathways in AD are still unclear. Here, we conducted a pathway analysis of a whole genome AD case-control expression dataset (n=41, 25 AD cases and 16 controls) from the human temporal cortex tissue. Using the differently expressed AD genes, we identified significant KEGG pathways related to metabolism and immune processes. Using the up- and down- regulated AD gene list, we further found up-regulated AD gene were significantly enriched in immune and metabolic pathways. We further compare the immune and metabolic KEGG pathways from the expression dataset with those from previous GWAS datasets, and found that most of these pathways are shared in both GWAS and expression datasets.

Keywords: Alzheimer’s disease; Pathology Section; expression data; pathway analysis.

MeSH terms

  • Alzheimer Disease / genetics*
  • Alzheimer Disease / immunology
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Case-Control Studies
  • Gene Expression Regulation*
  • Genetic Predisposition to Disease
  • Humans
  • Metabolic Networks and Pathways / genetics